NDAMENTALS INVESTOR EXPERIENCE MELBOURNE Wednesday 23 July 2025 for personal use only For personal use only For personal use only For personal use only NDAMENTALS INVESTOR EXPERIENCE MELBOURNE Wednesday 23 July 2025 for personal use only Today's rotations 2 3 / personal use only Optiflow & NIV in Neonatal Optiflow on Anaesthesia the ED Care the Ward With Dr Gerben Keijzers With Dr Peter Davis With Associate Professor With Professor Reny Segal and Associate Professor Benjamin Kwan Pierre Bradley Fisher & Pay ...

Image source: The Motley Fool.Tuesday, July 22, 2025 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Dave RosaChief Financial Officer — Jamie SamathChief Medical Officer — Dan ConnallyNeed a quote from one of our analysts? Email [email protected] RISKSJamie Samath stated, "pro forma gross margin was 67.9% in Q2 2025, down from 70% in Q2 2024." attributing the decline to "higher facilities costs," "a greater mix of lower-margin ION and da Vinci five revenue," and "higher service costs related to da ...

DUBLIN, IRELAND, July 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 first quarter results at 9:00 a.m. ET on August 7, 2025. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing financial results will be issued after ...

WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2025 financial results on August 5, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 5, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call ...

EDEN PRAIRIE, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, FDA-approved wound care products , today announced, that Morgan Frank, Chief Executive Officer, will present at the 45th Annual Canaccord Genuity Growth Conference, being held August 12–13, 2025, at the InterContinental Hotel in Boston, Massachusetts. Sanuwave’s group presentation is scheduled for Wednesday, August 13, from 9:30 to 9:55 a.m. ET. In addition to the presentation, ...

SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the second quarter of 2025 after the close of trading on Tuesday, August 5, 2025. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on August 5, 2025. Invest ...

ALACHUA, Fla. and TAMPA, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will report 2025 second quarter financial results on Tuesday, August 5, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the confer ...

Key Takeaways WST expects Q2 revenues of $720M-$730M and EPS of $1.50-$1.55, with organic sales up 3%-4%. WST's Proprietary Products segment is set to grow 4.6%, led by GLP-1 demand and SmartDose platform gains. WST's Contract Manufacturing gains from GLP-1 injectors as CGM volume winds down and new projects ramp.West Pharmaceutical Services (WST) is scheduled to release second-quarter 2025 results on July 24, before the opening bell. In the last reported quarter, the company delivered an earnings beat of ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Halozyme Therapeutics (HALO) , which belongs to the Zacks Medical - Biomedical and Genetics industry.When looking at the last two reports, this biopharmaceutical company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 12.73%, on average, in the last two quarters.For the most recent quarter, Halozyme Therapeut ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock characte ...